This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Recklinghausen, G.
Right arrow Articles by Ansorg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Recklinghausen, G.
Right arrow Articles by Ansorg, R.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, March 1998, p. 725-726, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Morphological Effects of Miconazole on Helicobacter pylori

    LETTER
Top
Letter
References

Helicobacter pylori is the causative agent of chronic superficial gastritis and contributes to the pathogenesis of peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma (4). The antimycotic miconazole has been shown to be bacteriostatically active against H. pylori (6, 8); however, details of the action of the substance are not known. The aim of the present study was therefore to investigate the morphological changes induced by miconazole.

H. pylori IMMi 95-451 was cultured microaerophilically in 3.0 ml of brain heart infusion broth (CM 225; Oxoid, Basingstoke, United Kingdom) supplemented with 10% newborn calf serum (no. 14-416 A; Serva, Heidelberg, Germany) and 0.25% yeast extract (no. 30-000-49; Flow, Meckenheim, Germany) (BNY broth) in tissue culture flasks with a volume of 50 ml (no. 690160; Greiner, Frickenhausen, Germany). The BNY broth cultures reached a cell density of at least 3 × 108 cells per ml. To obtain cultures with >90% intact and viable cells, two transfers of 1.5 ml of H. pylori culture in 1.5 ml of fresh BNY broth were made after 24 and 48 h. To the 48-h cultures, miconazole (Biotrend, Cologne, Germany) was added to reach a final concentration of 16 µg/ml. After another 24 h of incubation, 3.0-ml suspensions of treated cultures and controls without antibiotic were fixed for 1 h in 2% glutaraldehyde in cacodylate buffer (100 mmol) and then in 1% osmium tetroxide and 2% uranyl acetate. The organisms were deposited by centrifugations for 2 min at 8,000 × g. The final cell pellet was dehydrated in acetone and embedded in glycidether (Epon 812). Sections were mounted on copper grids and stained for 20 s with 4% lead citrate. Microphotographs were obtained with a Zeiss EM 10 transmission electron microscope at an accelerating voltage of 60 kV.

Most of the untreated control cells appeared as slightly curved or straight bacilli. The cells with intact membranes and a dense cytoplasm had a diameter of about 0.5 µm (Fig. 1A). Cultures exposed to miconazole for 24 h revealed few bacteria with intact shape and structure. Most cells were swollen, with diameters up to 1.5 µm, or heavily destroyed (Fig. 1B). However, intact flagellar and submembranous dense structures were still found in the treated cells. Round cell forms with intact cytoplasms and membranes were rarely found in treated cultures.


View larger version (143K):
[in this window]
[in a new window]
 
FIG. 1.   Effect of miconazole on the structure of H. pylori cells (strain IMMi 95-451). (A) Typically curved bacteria with polar flagellae in untreated controls are seen. (B) Swollen and destroyed bacteria predominate after treatment for 24 h with 16 µg of miconazole per ml. Bar represents 1 µm.

The inhibitory activity of miconazole (MIC range of 2 to 32 µg/ml) and of other nitroimidazole antimycotics against H. pylori was recently noted (6-8). Until now, bactericidal activity of miconazole against H. pylori has not been documented. The electron microscopic investigations prove the destructive action of miconazole on H. pylori. The replacement of the normal bacilliform morphology by cell wall blebbing, lytic cells, and vesiculation was similar to the changes seen with beta-lactam antibiotics, shown in an earlier study (2). However, in contrast to the observations of Berry et al. (3) on the effects of amoxicillin against H. pylori, round or coccoid cell forms were not induced by the miconazole treatment.

Imidazole antimycotics impair ergosterol synthesis of the cytoplasmic membrane in yeasts and molds. It can be speculated that these substances may interfere with cholesterol metabolism in H. pylori. This is unique and characteristic of this organism (1, 5).

    REFERENCES
Top
Letter
References

1. Ansorg, R., K.-D. Müller, G. von Recklinghausen, and H. P. Nalik. 1992. Cholesterol binding of Helicobacter pylori. Zentralbl. Bakteriol. 276:323-329[Medline].
2. Armstrong, J. A., S. H. Wee, C. S. Goodwin, and D. H. Wilson. 1987. Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro---an ultrastructural study. J. Med. Microbiol. 24:343-350[Abstract/Free Full Text].
3. Berry, V., K. Jennings, and G. Woodnutt. 1995. Bactericidal and morphological effects of amoxicillin on Helicobacter pylori. Antimicrob. Agents Chemother. 39:1859-1861[Abstract].
4. Blaser, M. J. 1995. Helicobacter pylori and related organisms, p. 1956-1964. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas and Bennett's principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
5. Hirai, Y., M. Haque, T. Yoshida, K. Yokota, T. Yasuda, and K. Oguma. 1995. Unique cholesteryl glycosides in Helicobacter pylori: composition and structural analysis. J. Bacteriol. 177:5327-5333[Abstract/Free Full Text].
6. Rautelin, H., O.-V. Renkonen, and T. U. Kosunen. 1992. In vitro activity of antifungal azoles against Helicobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 11:273-274[Medline]. (Letter.)
7. von Recklinghausen, G., C. di Maio, and R. Ansorg. 1992. Activity of the antimycotic ketoconazole against Helicobacter pylori. J. Antimicrob. Chemother. 30:238-240[Free Full Text]. (Letter.)
8. von Recklinghausen, G., C. di Maio, and R. Ansorg. 1993. Activity of antibiotics and azole antimycotics against Helicobacter pylori. Zentralbl. Bakteriol. 280:279-285[Medline].
G. von Recklinghausen
E. N. Schmid
A. Vollmer
R. Ansorg
Institute of Medical Microbiology
University of Essen
Hufelandstr. 55
D-45122 Essen
Germany


Antimicrobial Agents and Chemotherapy, March 1998, p. 725-726, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Recklinghausen, G.
Right arrow Articles by Ansorg, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Recklinghausen, G.
Right arrow Articles by Ansorg, R.